Scott Moore explores China’s trajectory in the global biotechnology sector. Although The us continues to be the dominant global participant in creating and commercializing biotechnology for decades, China is decided to be a number one participant in biotechnology which is investing closely from the sector. Moore argues that, while the U.S. is lik